Recently, the overexpression of CENPA was also identified in several human malignancies, including hepatocellular carcinoma (Li et al., 2011), colorectal cancer (Tomonaga et al., 2003), lung adenocarcinoma (Wu et al., 2012), breast cancer (McGovern et al., 2012), and ovarian cancer (Qiu et al., 2013). Here, CENPA is linked to ovarian carcinoma.